Today, the EVP & CFO of IntelGenx Technologies (IGXT), Andre Godin, bought shares of IGXT for $5,800.
Following this transaction Andre Godin’s holding in the company was increased by 8.57% to a total of $73.61K.
See today’s analyst top recommended stocks >>
The Company has a Price to Book ratio of 94.7798. Currently, IntelGenx Technologies has an average volume of 31.29K.
Starting in April 2018, IGXT received 10 Buy ratings in a row.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
IntelGenx Technologies Corp. engages in the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. Its products include rizaport, tadalafil, loxapine, and montelukast.
